Literature DB >> 2664621

Clinical presentation and diagnosis of endometriosis.

P C Galle1.   

Abstract

Endometriosis is one of the most common conditions encountered in gynecology and the field of infertility. The clinical presentation depends on the location and the extent of disease, but the severity of symptoms does not correlate directly with the extent of disease. Symptoms of genital endometriosis may be categorized as menstrual dysfunction, ovulatory dysfunction, and reproductive dysfunction. With menstrual dysfunction, the frequent clinical symptoms are cyclic pelvic pain, dysmenorrhea, and dyspareunia. Endometriosis is commonly found to be the cause in younger patients with pain and dysmenorrhea, particularly when the clinician is aware of the appearance of atypical lesions. Types of ovulatory dysfunction reported to be associated with endometriosis include anovulation, premenstrual spotting, luteal phase defects, and LUF syndrome. The data are not sufficient to determine the prevalence of endometriosis, luteal phase defects, and hyperprolactinemia. With LUF syndrome, there are data to support an association, but more data on the frequency of LUF in consecutive normal cycles compared to consecutive cycles in women with endometriosis would be beneficial. A higher rate of infertility is reported in couples with endometriosis. Two approaches are used to evaluate spontaneous abortions and endometriosis. In retrospective studies, the abortion rates are higher in couples with endometriosis; however, when the pregnancy outcomes in untreated couples are studied, there is less evidence to support the association of a higher spontaneous abortion rate. Formerly, the diagnosis of endometriosis depended on the appearance of typical lesions. With the recognition of early or atypical lesions the histologic confirmation of glands and stroma is assuming a more prominent role. Noninvasive techniques such as assays of endometrial antibodies or CA-125 have certain limitations in terms of producing false-positive results and lacking predictability in early stages of disease. Ultrasonography and MRI give additional and confirmatory information. Most noninvasive techniques are ancillary in diagnosis and management. It still needs to be determined whether their routine use will give enough added information to justify their cost. Currently, the diagnosis of endometriosis is best made by histologic evidence of glands and stroma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2664621

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  10 in total

Review 1.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

2.  Role of estrogen receptor signaling required for endometriosis-like lesion establishment in a mouse model.

Authors:  Katherine A Burns; Karina F Rodriguez; Sylvia C Hewitt; Kyathanahalli S Janardhan; Steven L Young; Kenneth S Korach
Journal:  Endocrinology       Date:  2012-06-14       Impact factor: 4.736

Review 3.  Epidemiology of endometriosis.

Authors:  P Mangtani; M Booth
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

4.  Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis.

Authors:  Jason M Franasiak; Katherine A Burns; Ov Slayden; Lingwen Yuan; Marc A Fritz; Kenneth S Korach; Bruce A Lessey; Steven L Young
Journal:  Reprod Sci       Date:  2014-07-16       Impact factor: 3.060

5.  NME1 suppression of endometrial stromal cells promotes angiogenesis in the endometriotic milieu via stimulating the secretion of IL-8 and VEGF.

Authors:  Kai-Kai Chang; Li-Bing Liu; Li-Ping Jin; Yu-Han Meng; Jun Shao; Ying Wang; Jie Mei; Ming-Qing Li; Da-Jin Li
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

6.  Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis.

Authors:  Daniel Escorsim Machado; Karina Cristina Rodrigues-Baptista; Jessica Alessandra-Perini; Roberto Soares de Moura; Thiago Alves Dos Santos; Kariny Gomes Pereira; Yasmin Marinho da Silva; Pergentino José Cunha Souza; Luiz Eurico Nasciutti; Jamila Alessandra Perini
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

7.  Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells.

Authors:  Corinne Iampietro; Alessia Brossa; Stefano Canosa; Stefania Tritta; Glenn E Croston; Torsten Michael Reinheimer; Filippo Bonelli; Andrea Roberto Carosso; Gianluca Gennarelli; Stefano Cosma; Chiara Benedetto; Alberto Revelli; Benedetta Bussolati
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

Review 8.  Endometriosis: A Review of Clinical Diagnosis, Treatment, and Pathogenesis.

Authors:  Saurabh Chauhan; Akash More; Vaishnavi Chauhan; Aditya Kathane
Journal:  Cureus       Date:  2022-09-06

9.  Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases.

Authors:  Daniel E Machado; Plínio T Berardo; Celia Y Palmero; Luiz E Nasciutti
Journal:  J Exp Clin Cancer Res       Date:  2010-01-19

10.  Isolated ureteric endometriosis presenting as a ureteric tumor.

Authors:  Raouf Seyam; Alaa Mokhtar; Waleed Al Taweel; Ahmed Al Sayyah; Asma Tulbah; Waleed Al Khudair
Journal:  Urol Ann       Date:  2014-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.